Kappos L - Search Results

1

A comparative study of CSF neurofilament light and heavy chain protein in MS.

Kuhle J, Plattner K, Bestwick JP, Lindberg RL, Ramagopalan SV, Norgren N, Nissim A, Malaspina A, Leppert D, Giovannoni G, Kappos L. Kuhle J, et al. Among authors: kappos l. Mult Scler. 2013 Oct;19(12):1597-603. doi: 10.1177/1352458513482374. Epub 2013 Mar 25. Mult Scler. 2013. PMID: 23529999

2

Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis.

Leppert D, Ford J, Stabler G, Grygar C, Lienert C, Huber S, Miller KM, Hauser SL, Kappos L. Leppert D, et al. Among authors: kappos l. Brain. 1998 Dec;121 ( Pt 12):2327-34. doi: 10.1093/brain/121.12.2327. Brain. 1998. PMID: 9874483

3

Increase in serum levels of uric acid, an endogenous antioxidant, under treatment with glatiramer acetate for multiple sclerosis.

Constantinescu CS, Freitag P, Kappos L. Constantinescu CS, et al. Among authors: kappos l. Mult Scler. 2000 Dec;6(6):378-81. doi: 10.1177/135245850000600603. Mult Scler. 2000. PMID: 11212132 Clinical Trial.

4

The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis.

Lindberg RL, De Groot CJ, Montagne L, Freitag P, van der Valk P, Kappos L, Leppert D. Lindberg RL, et al. Among authors: kappos l. Brain. 2001 Sep;124(Pt 9):1743-53. doi: 10.1093/brain/124.9.1743. Brain. 2001. PMID: 11522577

5

Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis.

Leppert D, Lindberg RL, Kappos L, Leib SL. Leppert D, et al. Among authors: kappos l. Brain Res Brain Res Rev. 2001 Oct;36(2-3):249-57. doi: 10.1016/s0165-0173(01)00101-1. Brain Res Brain Res Rev. 2001. PMID: 11690622 Review.

6

Neutralizing antibodies against IFN-beta in multiple sclerosis: antagonization of IFN-beta mediated suppression of MMPs.

Gilli F, Bertolotto A, Sala A, Hoffmann F, Capobianco M, Malucchi S, Glass T, Kappos L, Lindberg RL, Leppert D. Gilli F, et al. Among authors: kappos l. Brain. 2004 Feb;127(Pt 2):259-68. doi: 10.1093/brain/awh028. Epub 2003 Nov 7. Brain. 2004. PMID: 14607790

7

Multiple sclerosis as a generalized CNS disease--comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS.

Lindberg RL, De Groot CJ, Certa U, Ravid R, Hoffmann F, Kappos L, Leppert D. Lindberg RL, et al. Among authors: kappos l. J Neuroimmunol. 2004 Jul;152(1-2):154-67. doi: 10.1016/j.jneuroim.2004.03.011. J Neuroimmunol. 2004. PMID: 15223248

8

Alternatives to current disease-modifying treatment in MS: what do we need and what can we expect in the future?

Kappos L, Kuhle J, Gass A, Achtnichts L, Radue EW. Kappos L, et al. J Neurol. 2004 Sep;251 Suppl 5:v57-v64. doi: 10.1007/s00415-004-1509-6. J Neurol. 2004. PMID: 15549357 Review.

9

Genomics and proteomics: role in the management of multiple sclerosis.

Kappos L, Achtnichts L, Dahlke F, Kuhle J, Naegelin Y, Sandbrink R, Lindberg RL. Kappos L, et al. J Neurol. 2005 Sep;252 Suppl 3:iii21-iii27. doi: 10.1007/s00415-005-2013-3. J Neurol. 2005. PMID: 16170496 Review.

10

Gelatinase B [matrix metalloproteinase (MMP)-9] and collagenases (MMP-8/-13) are upregulated in cerebrospinal fluid during aseptic and bacterial meningitis in children.

Lindberg RL, Sorsa T, Tervahartiala T, Hoffmann F, Mellanen L, Kappos L, Schaad UB, Leib SL, Leppert D. Lindberg RL, et al. Among authors: kappos l. Neuropathol Appl Neurobiol. 2006 Jun;32(3):304-17. doi: 10.1111/j.1365-2990.2006.00729.x. Neuropathol Appl Neurobiol. 2006. PMID: 16640649

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

807 results

Search Page

Filters